217 related articles for article (PubMed ID: 1695425)
1. Inhibition of histamine release from human lung and rat peritoneal mast cells by cyclosporin-A.
Ezeamuzie IC; Assem ES
Agents Actions; 1990 Apr; 30(1-2):110-3. PubMed ID: 1695425
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells.
Pedersen C; Permin H; Stahl Skov P; Norn S; Svenson M; Mosbech H; Bendtzen K
Allergy; 1985 Feb; 40(2):103-7. PubMed ID: 2581463
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells.
Marone G; Triggiani M; Cirillo R; Giacummo A; Siri L; Condorelli M
Ric Clin Lab; 1988; 18(1):53-9. PubMed ID: 2453912
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues.
Takei M; Matumoto T; Endo K; Muramatu M
Agents Actions; 1988 Aug; 25(1-2):17-21. PubMed ID: 2461059
[TBL] [Abstract][Full Text] [Related]
5. Effect of loop diuretics on rat peritoneal and human lung mast cells.
Redrup AC; Pearce FL
Agents Actions; 1994 Jun; 41 Spec No():C47-8. PubMed ID: 7526657
[TBL] [Abstract][Full Text] [Related]
6. The effect of platelet-activating factor on histamine release from guinea pig peritoneal mast cells.
Misawa M; Huang SC; Chiu MH
J Pharmacobiodyn; 1991 Feb; 14(2):61-5. PubMed ID: 1714503
[TBL] [Abstract][Full Text] [Related]
7. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
Yanagihara Y; Kasai H; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
[TBL] [Abstract][Full Text] [Related]
8. Effect of ecdysterone on histamine release from rat peritoneal mast cells.
Takei M; Endo K; Nishimoto N; Shiobara Y; Inoue S; Matsuo S
J Pharm Sci; 1991 Apr; 80(4):309-10. PubMed ID: 1713963
[TBL] [Abstract][Full Text] [Related]
9. Effect of dantrolene on histamine release from rat peritoneal mast cells.
Takei M; Urashima H; Endo K
Agents Actions; 1991 Mar; 32(3-4):213-6. PubMed ID: 1713734
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipine.
Kim YY; Holgate ST; Church MK
Br J Clin Pharmacol; 1985 May; 19(5):631-8. PubMed ID: 2408645
[TBL] [Abstract][Full Text] [Related]
11. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
12. Urinary trypsin inhibitor reduces the release of histamine from rat peritoneal mast cells.
Kobayashi H; Shibata K; Fujie M; Terao T
J Lab Clin Med; 1998 Apr; 131(4):375-85. PubMed ID: 9579392
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in histamine release from human basophils and rat peritoneal mast cells.
Peh KH; Moulson A; Wan BY; Assem EK; Pearce FL
Eur J Pharmacol; 2001 Aug; 425(3):229-38. PubMed ID: 11513842
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).
Ezeamuzie CI; Assem ES
Immunopharmacology; 1990; 20(1):31-43. PubMed ID: 1699910
[TBL] [Abstract][Full Text] [Related]
15. Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells.
Iikura M; Takaishi T; Hirai K; Yamada H; Iida M; Koshino T; Morita Y
Int Arch Allergy Immunol; 1998 Feb; 115(2):129-36. PubMed ID: 9482701
[TBL] [Abstract][Full Text] [Related]
16. The activity of compounds extracted from feverfew on histamine release from rat mast cells.
Hayes NA; Foreman JC
J Pharm Pharmacol; 1987 Jun; 39(6):466-70. PubMed ID: 2441022
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.
Triggiani M; Cirillo R; Lichtenstein LM; Marone G
Int Arch Allergy Appl Immunol; 1989; 88(1-2):253-5. PubMed ID: 2468619
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits rat mast cell activation.
Dráberová L
Eur J Immunol; 1990 Jul; 20(7):1469-73. PubMed ID: 1696892
[TBL] [Abstract][Full Text] [Related]
19. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
Yanagihara Y; Abe T; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
[TBL] [Abstract][Full Text] [Related]
20. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
